La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Melexis Croissance future
Future contrôle des critères 2/6
Melexis devrait augmenter ses bénéfices et son chiffre d'affaires de 6.5% et de 7.1% par an respectivement. Le BPA devrait croître de de 6.5% par an. Le rendement des capitaux propres devrait être 35.7% dans 3 ans.
Informations clés
6.5%
Taux de croissance des bénéfices
6.5%
Taux de croissance du BPA
Semiconductor croissance des bénéfices | 22.2% |
Taux de croissance des recettes | 7.1% |
Rendement futur des capitaux propres | 35.7% |
Couverture par les analystes | Good |
Dernière mise à jour | 05 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
There's Reason For Concern Over Melexis NV's (EBR:MELE) Price
Aug 19Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Aug 02A Look At The Fair Value Of Melexis NV (EBR:MELE)
Jul 04Is There Now An Opportunity In Melexis NV (EBR:MELE)?
Jun 20Melexis (EBR:MELE) Knows How To Allocate Capital
Jun 07Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment
May 08Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Should You Think About Buying Melexis NV (EBR:MELE) Now?
Nov 18Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 29Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 15Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around
Jul 18Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jun 21These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely
Jun 08Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price
Apr 11What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?
Mar 17Is Melexis (EBR:MELE) Likely To Turn Things Around?
Feb 28Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 1,169 | 248 | 212 | 273 | 11 |
12/31/2025 | 1,071 | 222 | 203 | 267 | 11 |
12/31/2024 | 995 | 201 | 157 | 239 | 11 |
6/30/2024 | 987 | 209 | 70 | 153 | N/A |
3/31/2024 | 978 | 211 | -91 | 3 | N/A |
12/31/2023 | 964 | 209 | -92 | 3 | N/A |
9/30/2023 | 938 | 212 | -74 | 7 | N/A |
6/30/2023 | 909 | 204 | -21 | 42 | N/A |
3/31/2023 | 881 | 199 | 132 | 184 | N/A |
12/31/2022 | 836 | 197 | 148 | 188 | N/A |
9/30/2022 | 779 | 178 | 158 | 194 | N/A |
6/30/2022 | 722 | 166 | 124 | 161 | N/A |
3/31/2022 | 672 | 152 | 105 | 140 | N/A |
12/31/2021 | 644 | 131 | 103 | 142 | N/A |
9/30/2021 | 625 | 122 | 95 | 132 | N/A |
6/30/2021 | 584 | 100 | 92 | 123 | N/A |
3/31/2021 | 525 | 76 | 80 | 109 | N/A |
12/31/2020 | 508 | 69 | 71 | 96 | N/A |
9/30/2020 | 487 | 61 | 72 | 95 | N/A |
6/30/2020 | 489 | 61 | 81 | 104 | N/A |
3/31/2020 | 509 | 67 | 75 | 101 | N/A |
12/31/2019 | 487 | 60 | 68 | 94 | N/A |
9/30/2019 | 501 | 73 | 67 | 105 | N/A |
6/30/2019 | 525 | 88 | 45 | 96 | N/A |
3/31/2019 | 547 | 101 | 35 | 98 | N/A |
12/31/2018 | 569 | 115 | 23 | 100 | N/A |
9/30/2018 | 560 | 114 | 5 | 78 | N/A |
6/30/2018 | 541 | 112 | 22 | 89 | N/A |
3/31/2018 | 527 | 114 | N/A | 106 | N/A |
12/31/2017 | 512 | 111 | N/A | 113 | N/A |
9/30/2017 | 499 | 109 | N/A | 116 | N/A |
6/30/2017 | 486 | 107 | N/A | 96 | N/A |
3/31/2017 | 470 | 99 | N/A | 108 | N/A |
12/31/2016 | 456 | 96 | N/A | 108 | N/A |
9/30/2016 | 439 | 93 | N/A | 116 | N/A |
6/30/2016 | 426 | 93 | N/A | 134 | N/A |
3/31/2016 | 415 | 95 | N/A | 127 | N/A |
12/31/2015 | 400 | 99 | N/A | 115 | N/A |
9/30/2015 | 386 | 97 | N/A | 109 | N/A |
6/30/2015 | 371 | 97 | N/A | 103 | N/A |
3/31/2015 | 351 | 93 | N/A | 97 | N/A |
12/31/2014 | 332 | 85 | N/A | 95 | N/A |
9/30/2014 | 319 | 81 | N/A | 95 | N/A |
6/30/2014 | 304 | 71 | N/A | 84 | N/A |
3/31/2014 | 289 | 63 | N/A | 80 | N/A |
12/31/2013 | 275 | 55 | N/A | 71 | N/A |
9/30/2013 | 262 | 56 | N/A | 57 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de MELE ( 6.5% par an) est supérieure au taux d'épargne ( 1.3% ).
Bénéfices vs marché: Les bénéfices de MELE ( 6.5% par an) devraient croître plus lentement que le marché Belgian ( 19.4% par an).
Croissance élevée des bénéfices: Les bénéfices de MELE devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de MELE ( 7.1% par an) devrait croître plus lentement que le marché de Belgian ( 7.1% par an).
Croissance élevée des revenus: Le chiffre d'affaires de MELE ( 7.1% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de MELE devrait être élevé dans 3 ans ( 35.7 %)